A (b)(6) male patient with newly diagnosed glioblastoma began optune therapy on (b)(6) 2021.On (b)(6) 2022, patient reported lower compliance with optune therapy due to a skin issue.The physician prescribed unspecified treatment.On (b)(6) 2022, novocure was informed the patient had lower usage due to a hospitalization and a skin issue described as an abscess on the back of the scalp.On (b)(6) 2022, novocure employee confirmed the patient was hospitalized and underwent surgery for the abscess on the scalp.The prescribing physician did not provide any additional information or a causality assessment to the event.
|